NO20082358L - S-omeprazole stronsium or hydrate thereof, process for preparation thereof, and pharmaceutical composition comprising these - Google Patents

S-omeprazole stronsium or hydrate thereof, process for preparation thereof, and pharmaceutical composition comprising these

Info

Publication number
NO20082358L
NO20082358L NO20082358A NO20082358A NO20082358L NO 20082358 L NO20082358 L NO 20082358L NO 20082358 A NO20082358 A NO 20082358A NO 20082358 A NO20082358 A NO 20082358A NO 20082358 L NO20082358 L NO 20082358L
Authority
NO
Norway
Prior art keywords
hydrate
preparation
pharmaceutical composition
omeprazole
stronsium
Prior art date
Application number
NO20082358A
Other languages
Norwegian (no)
Inventor
Eun Young Kim
Tae Hee Ha
Hee Sook Oh
Won Jeoung Kim
Chang Hee Park
Young Hoon Kim
Kwee Hyun Suh
Gwan Sun Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of NO20082358L publication Critical patent/NO20082358L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

Oppfinnelsen tilveiebringer S-omeprazolstrontium eller et hydrat derav for forhindring eller behandling av en magesyre-relatert sykdom, som har høy optisk renhet, termostabilitet, løselighet og ikke-hygroskopisitet, en fremgangsmåte for fremstilling derav, og et farmasøytisk preparat omfattende dette.The invention provides S-omeprazole strontium or a hydrate thereof for the prevention or treatment of a gastric acid-related disease having high optical purity, thermostability, solubility and non-hygroscopicity, a process for its preparation, and a pharmaceutical composition comprising this.

NO20082358A 2005-10-26 2008-05-23 S-omeprazole stronsium or hydrate thereof, process for preparation thereof, and pharmaceutical composition comprising these NO20082358L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20050101059 2005-10-26
KR2006000760 2006-03-06
PCT/KR2006/004369 WO2007049914A1 (en) 2005-10-26 2006-10-25 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Publications (1)

Publication Number Publication Date
NO20082358L true NO20082358L (en) 2008-07-25

Family

ID=37967988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082358A NO20082358L (en) 2005-10-26 2008-05-23 S-omeprazole stronsium or hydrate thereof, process for preparation thereof, and pharmaceutical composition comprising these

Country Status (8)

Country Link
JP (1) JP5017274B2 (en)
AU (1) AU2006306906B2 (en)
CA (1) CA2626085C (en)
IL (1) IL190709A (en)
MY (1) MY140986A (en)
NO (1) NO20082358L (en)
RU (1) RU2372345C1 (en)
WO (1) WO2007049914A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (en) * 1983-03-04 1983-03-04 Haessle Ab NOVEL COMPOUNDS
SE510650C2 (en) * 1997-05-30 1999-06-14 Astra Ab New association
WO2004099182A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Zinc salt of (s)-omeprazole
ATE386522T1 (en) * 2003-07-23 2008-03-15 Nycomed Gmbh ALKALINE SALTS OF PROTON PUMP INHIBITORS
RU2007145207A (en) * 2005-05-06 2009-06-20 Гленмарк Фармасьютикалз Лимитед (In) ESOMEPRAZOL STRONGTED SALT, METHOD FOR PRODUCING IT AND CONTAINING ITS PHARMACEUTICAL COMPOSITIONS

Also Published As

Publication number Publication date
JP5017274B2 (en) 2012-09-05
IL190709A0 (en) 2008-11-03
MY140986A (en) 2010-02-12
RU2372345C1 (en) 2009-11-10
CA2626085A1 (en) 2007-05-03
CA2626085C (en) 2011-12-06
AU2006306906B2 (en) 2010-02-04
WO2007049914A1 (en) 2007-05-03
IL190709A (en) 2012-03-29
JP2009513625A (en) 2009-04-02
AU2006306906A1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
NO20092274L (en) Ansamycin formulations and methods of use thereof
NO20091700L (en) Florizine analogues as inhibitors of glucose co-transporter 2
HK1104035A1 (en) Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same
NO20053972L (en) Amino acid derived prodrug of propofol, compositions and use thereof.
NO20092609L (en) Tannate salt or rasagiline
WO2007136577A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
NO20083923L (en) Pyrazole quinolones are potent parp inhibitors
DK1984357T3 (en) 2,4-PYRIMIDINE DIAMINE COMPOUNDS FOR TREATMENT OR PREVENTION OF AUTO-IMMUNE DISEASES
DK1971601T3 (en) N4-phenylquinazoline-4-amine derivatives and related compounds as ERBB Type 1 receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
NO20083918L (en) Dihydridiazepines useful as inhibitors of protein kinases
NO20080122L (en) Mixture of diisononyl esters of 1,2-cyclodicarboxylic acids, processes for the preparation and use thereof
TN2009000111A1 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
NO20092398L (en) Crystalline forms of solvated ilaprazole
DK1855677T3 (en) 3.11 B-CIS dihydrotetrabenzene for the treatment of schizophrenia and other psychoses
NO20054876D0 (en) Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as drug and drug containing such compounds
WO2007120575A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
NO20081160L (en) Benzimidazolthiophene Compounds
NO20083836L (en) N hydroksyakrylamidforbindelser
NO20082758L (en)
WO2007075749A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
NO20082938L (en) Formulations of quinolinones
DK1879580T3 (en) 4-Phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as drugs for the treatment of infertility
BRPI0622083A2 (en) METHOD AND APPARATUS FOR THE MANUFACTURE OF PURIFIED SUBSTRATES OR PURE SUBSTRATES WHICH ARE ADDITIONAL PROCESSED.
CL2007003875A1 (en) COMPOUNDS DERIVED FROM AMIDAS OF THE 3-AMINO TETRAHYDROFURAN-3-CARBOXYL ACID; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS.
NO20083751L (en) Methods for the treatment of cognitive and other diseases

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: TANDBERGS PATENTKONTOR AS, POSTBOKS

FC2A Withdrawal, rejection or dismissal of laid open patent application